Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q2 2015 · 10-Q
Revenue$227.58M$227.58Mno prior Q2 2014 on file Net Income$7.49M$7.49Mno prior Q2 2014 on file EPS Diluted$0.14$0.14no prior Q2 2014 on file Gross Profit$108,114,000— Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$31,242,000— Free Cash Flowderived-$2,545,000— Margins · derivedGross margin47.5%
Operating margin5.5%
Net margin3.3%
ended Sep 27, 2014 · filed Nov 4, 2014 · 38 d after period end